Third Rock Ventures IV, L.P.

Third Rock Ventures IV, L.P. is listed in filings as 10% Owner at Maze Therapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 5, 2025, including sale activity. Recent filings connect the profile to Maze Therapeutics, Inc. (MAZE) and Tango Therapeutics, Inc. (TNGX). The current snapshot covers public activity from Jul 18, 2024 to Nov 5, 2025. Reported amounts are shown as $4.8M to $2.6M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.